The technique of in-vitro fertilization (IVF) entails fertilizing egg cells outside of the woman's body with sperm before implanting them in the uterus. This kind of treatment uses assisted reproductive technology (ART) to help treat infertility or genetic issues so that a child can be conceived. It is the procedure of fertilization, which entails removing the sperm and egg cells and physically mixing them in a lab to create an embryo. The embryo(s) are then placed in the uterus to continue with the gestation process. IVF is frequently utilized in situations of infertility resulting from a variety of causes, including male infertility, blocked fallopian tubes, and ovulation abnormalities, or when other reproductive treatments have failed.
According to SPER market research, ‘Europe In-Vitro Fertilization Market Size - By Cycle Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Europe In-Vitro Fertilization Market is predicted to reach USD 7.28 billion by 2033 with a CAGR of 5.6%.
The European IVF market is expected to be driven by a number of factors, including growing public and private sector participation in the IVF market, growing support for the expansion of infertility clinics and services throughout the European region, a growing emphasis on fertility protection initiatives among market participants, and education to strengthen the network for exchanging best practices and succinct information on infertility and fertility. Furthermore, it is projected that the IVF industry will continue to expand because these institutions work to remove the stigma attached to infertility by offering public support for all reproductive treatment options. The expansion of the European IVF business is also being aided by rising awareness of the range of infertility treatment options available. Additionally, the market players' growing efforts to raise awareness of infertile clinics and infertility treatments aid in raising awareness of the treatment procedure.
On the other hand, cost is a significant obstacle, with many couples finding that the costs of therapy are too high. Furthermore, ethical questions about the use of assisted reproductive technologies might lead to regulatory obstacles and public scepticism. Multiple pregnancies and birth issues are among the negative effects of IVF therapy that frequently hinder its usage. The percentage of IVF success is based on the number of embryos transferred, which can lead to multiple pregnancies which can result in complications including high blood pressure and problems during delivery. Moreover, several pregnancies might lead to a child's health problems, such as low birth weight and premature delivery.
Impact of COVID-19 on Europe IVF Market
The COVID-19 pandemic caused a slodown in the growth of the Europe IVF services market. Lockdowns were imposed at the national level in many countries, delaying flights, imposing travel restrictions and quarantines, cancelling all indoor and outdoor events, and issuing emergency declarations. All of these measures directly affected fertility tourism. Since doctors had direct contact with patients seeking IVF therapy, they decided to postpone elective fertility treatments and discourage non-urgent patient visits to reproductive clinics. As a result, these factors led to the cancellation of many scheduled IVF procedures and prevented the growth of the Asia-Pacific IVF services market during the pandemic.
Europe In-Vitro Fertilization Market Key Players:
Countries like UK, Germany, and France have excellent market growth prospects due to falling birth rates, and a supportive regulatory function. Additionally, the key market players in this market are Cadila Healthcare Ltd., DRK Kliniken Berlin, EMD Serono Inc., LG Life Sciences, Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and others.
For More Information, refer to below link:-
Europe In-Vitro Fertilization (IVF) Market Outlook
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant – U.S.A.
SPER Market Research
+1-347-460-2899
